FDA Advisory Panel Recommends Approval Of Sanofi-AstraZeneca Shot For Preventing RSV In Infants

The New York Times (6/8, Jewett) reports, “A Food and Drug Administration advisory panel recommended approval of a monoclonal antibody shot aimed at preventing a potentially lethal pathogen, respiratory syncytial virus, or R.S.V., in infants and vulnerabl...